Palestrantes Internacionais

Carlos Rábade

Neumólogo en Complejo Hospitalario Universitario de Santiago de Compostela.
Responsable del área de Tabaquismo de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), sobre avances en Neumología, como la criobiopsia para el estudio de la enfermedad pulmonar intersticial y la ecobroncoscopia en los hospitales de España.
Carlos Rábade

Claudia Crimi

Prof. Claudia Crimi is an Associate Professor of Respiratory Medicine at the University of Catania and Director of the Respiratory Intensive Care Unit at Policlinico “G. Rodolico-San Marco” University Hospital in Catania where she also serves as a consultant in the respiratory unit and outpatient clinic. She completed her residency in respiratory diseases at University of Catania and her research fellowship at the Department of Anaesthesia and Critical Care at Massachusetts General Hospital, Harvard University in Boston, USA. She holds a PhD in Respiratory Diseases from the University of Catania. Her research interests focus on severe asthma and non-invasive ventilation techniques in acute and chronic settings, particularly for patients with chronic obstructive pulmonary disease (COPD) and bronchiectasis. Prof. Crimi has published extensively, with 136 papers in Scopus and 150 in PubMed, and an h-index of 35. Active in clinical trials focused on respiratory support, particularly during COVID-19. She is currently the Secretary of the European Respiratory Society Group 02.02 on Noninvasive ventilatory support and co-chair of the European Respiratory Society Task Force on Telemonitoring in Home Mechanical Ventilation.
Claudia Crimi

James Chalmers

Professor of Respiratory Research, University of Dundee, and Chair of the European Bronchiectasis Registry. Chief Editor of the European Respiratory Journal.
James Chalmers

Javier Barcala

Profesor titular de neumología de la Universidad de Santiago de Compostela (acreditación ANECA para catedrático)
Médico especialista en neumología-Hospital Clínico Universitario de Santiago de Compostela
Líder del grupo de investigación: Translational Research in Airway Diseases-Fundación de investigación sanitaria de Santiago de Compostela (https://www.idisantiago.es/en/grupo-de-investigacion/ac20-investigacion-traslacional-de-enfermedades-de-la-via-aerea/)
Profesor de postgrado Universidad de South Wales (Cardiff)
Editor asociado actualmente de ERJ-Open Research, BMC Pulmonary Medicine y Open Respiratory Archives
Mentor del Early Career Mentorship Programme de la ERS
Director de 15 tesis doctorales
Autor de más de 250 publicaciones indexadas en pubmed
Estancia científica Hôpital Arnaud de Villeneuve-Montpellier (Francia)
Miembro o exmiembro de los comités de SEPAR: enfermedades respiratorias ocupacionales y medioambientales, pregrado, gestión documental, proyectos integrados de investigación del área de asma.
Javier Barcala

Johan Verbraecken

Johan Verbraecken is medical coordinator of the Multidisciplinary Sleep Disorders Centre of the Antwerp University Hospital (Belgium). He started respiratory sleep medicine in 1990 and performed a two year research fellowship on “Mechanisms of unstable breathing during sleep in men”. After his training as pulmonologist and PhD defence (1998), he became staff member at the Maastricht University Medical Centre, The Netherlands. Since 2001 he is staff member at the Antwerp University Hospital, Belgium, and currently associate professor and training director for pulmonology at the University of Antwerp. At the European level he was secretary and chair of the ERS Sleep and Control of Breathing Group, ERS E-Learning Director, chair of the ERS Accreditation Review Committee for respiratory training centres, member Executive Committee of the Assembly of National Sleep Societies, and co-opted ESRS Board member. Currently he is past-president of the Belgian Association for Sleep research and Sleep medicine. He chaired different Task Forces (ERS TF Non-CPAP therapies in obstructive sleep apnoea, ERS TF on Central sleep apnoea, ERS TF on Telemedicine, ESRS TF Beyond the AHI and ESRS TF BiPAP therapy in obstructive and central sleep apnoea). Prof Verbraecken is also chief-editor of different major text books, among them the textbook “Sleep and sleep Disorders. A practical handbook”.
Johan Verbraecken

Jordi Remon

Dr Jordi Remon, MD, PhD is medical oncologist currently working as consultant in the Thoracic Oncology Department at Gustave Roussy (France). Dr Remon deals with patients with lung cancer, as well as mesothelioma and thymic malignancies. Dr Remon is member from ESMO, EORTC (secretary of Lung Cancer Group since January 2021), IASLC, and SLCG.
Jordi Remon

Luis Máiz

Nacido en Santiago de Compostela, 25 de enero de 1964
FORMACIÓN ACADÉMICA PREGRADO
- Licenciado en Medicina. 1983-1989
- Facultad de Medicina. Universidad Autónoma de Madrid.
- Doctorado en Medicina. Apto cum laude. Premio Extraordinario de Doctorado. 1999. Universidad de Alcalá. Alcalá de Henares. “Respuesta inmune al Aspergillus fumigatus y a la Candida albicans en pacientes con fibrosis quística.”
- Profesor asociado de la Universidad de Medicina de Alcalá de Henares
- Jefe de Sección de Infección Bronquial Crónica
ACTIVIDAD DOCENTE
- Comunicaciones a congresos:
- Internacionales: 46
- Nacionales: 118
- Publicaciones en revistas indexadas
- Internacionales: 67
- Nacionales: 64
- Capítulos de libros de difusión internacional: 6
- Dirección de monografías y libros en revistas nacionales: 7
- Capítulos de libros de difusión nacional: 35
- Proyectos de investigación por administraciones privadas: 32
- Proyectos de investigación financiados por organismos oficiales: 3
Luis Máiz

Luis M. Seijo

I am a clinical practitioner and researcher with extensive experience in respiratory medicine, endoscopy and lung cancer. I obtained my B.A. from Columbia College in 1990 and MD from the University of Pennsylvania School of Medicine in 1995, followed by a PhD from the Universidad de Navarra in 2015. I trained in pulmonary medicine, critical care and internal medicine at the Hospital of the University of Pennsylvania and am currently active in various research projects including endoscopy, lung cancer screening with low dose CT, biomarkers of early stage lung cancer, artificial intelligence, metabolomics, and biomarkers in COPD, sleep disordered breathing, and lung cancer. I was principal investigator in two clinical studies linking sleep disordered breathing and lung cancer and recently received a grant from the instituto de salud Carlos III in order to continue investigating the links between nocturnal hypoxemia and lung cancer. I am also the principal investigator in Spain for a EU4Health grant as a member of the SOLACE lung cancer screening consortium and have received funding as a member of the SPACETIME consortium also funded by the EU. I am also active in research in radiomics applied to lung cancer and emphysema, as well as COVID 19 and participated in several clinical trials during the pandemic. I coordinated the CIBERES lung cancer research strategy from 2016 to 2018 in Spain and thoracic oncology for the Spanish thoracic society (SEPAR) between 2021 and 2023. I coordinated the year of early lung cancer detection for SEPAR between 2023 and 2024 hosting the first iberoamerican summit on lung cancer screening in Granada in 2023, the SOLACE 2024 consortium meeting and the first AGILE meeting in may of 2024. I am co-coordinator of the Spanish national lung cancer screening pilot known as CASSANDRA and principal investigator in Spain for the Pamplona iELCAP lung cancer screening investigator site. Finally, I am the current director of the pulmonary medicine department of the Clínica Universidad de Navarra and ERS representative in the European Cancer Organization.
Luis M. Seijo

Manel Luján Torné

Head of the Pulmonology Department at Hospital Universitari Parc Taulí (Sabadell, Barcelona).
Coordinator of the national consensus on non-invasive support in acute respiratory failure and the specific national consensus on COVID-19.
Coordinator of the Integrated Research Program (PII) of the Spanish Society of Pulmonology (SEPAR).
Member of the international SOMNONIV group for the study of monitoring in patients under non-invasive mechanical ventilation (NIV) and co-author of the European Task Force on non-invasive ventilation in stable COPD.
Manel Luján Torné

Marieke Duiverman

Marieke Duiverman is pulmonologist at the University Medical Center Groningen, The Netherlands. She is one of the medical doctors of the Home Mechanical Ventilation Center Groningen, part of the department of pulmonary diseases of this hospital. Next to clinical work, Marieke educates medical students from the University Groningen and has a strong connection with the University Twente, one of the main technical universities, both for educational activities and research.
Marieke Duiverman has her main research interests in long-term respiratory and ventilatory assistance in severe COPD. She performed one of the first RCTs in stable COPD, comparing rehabilitation alone with the combination rehabilitation + nocturnal NIV in stable hypercapnic COPD. This was one of the first studies showing clear benefit of the addition of nocturnal NIV in this group. More recently, she performed a RCT in which we aimed to improve and facilitate the way patients are initiated on NIV; we investigated whether home initiation was non-inferior to the standard home initiation. This was the first randomised controlled trial showing that home initiation of chronic NIV in COPD patients with chronic hypercapnic respiratory failure is non-inferior to hospital initiation, and is associated with savings of over 50% of the costs. A second field of interest concerns nasal high flow therapy, in current COVID-19 times but also in the treatment of stable and post-exacerbation COPD. Marieke Duiverman is leader of a multicentre trial investigating this therapy in the post-exacerbation situation. Finally, Marieke has special interest in optimal but non-invasive and robust monitoring during long-term NIV and the application of more detailed monitoring facilities such as respiratory EMG, patient-ventilator asynchrony and lung mechanics during long-term NIV. Marieke has published 57 articles of the above mentioned topics in respiratory journals.
Marieke Duiverman is currently chair of the group 2.2 non-invasive ventilatory support of the assembly 2 respiratory intensive care. As such, in collaboration with many colleagues across and outside Europe she is chairing a clinical practice guideline on telemonitoring in HMV and a the recently granted clinical research collaboration “IMPORTANCE” aiming to develop an international collaboration and registry on sleep-disordered breathing and HMV.
Marieke Duiverman

Mine Orlu

Professor Orlu is globally recognised researcher in patient centric drug delivery systems design. Her research team focuses on the use of novel emerging engineering, machine learning and digital health technologies for optimised therapeutic outcomes. Her research has been funded by EU funding schemes, UKRI EPSRC, charities and pharmaceutical industry. She has published over 100 peer-reviewed papers, 7 book chapters and taken a co-Editor role for 1 book. She is currently Professor of Pharmaceutics and Devices & Diagnostics Therapeutic Innovation Network at University College London.
Mine Orlu

Rosário Campelo

Dr Rosario García Campelo MD, PhD is the Head of Medical Oncology Department, Thoracic Tumor Unit Chair in the University Hospital A Coruña, Spain, and Head of Oncology Research Group, Biomedical Research Institute (INIBIC), A Coruña, Spain. She obtained her medical degree in 1996 at the University of Santiago de Compostela, Spain, and subsequently completed his training in medical oncology in the University Hospital of A Coruña, Spain. She completed her training as a visiting researcher at the laboratory of Molecular Biology of the Germa Hospital Trias i Pujol (Barcelona, Spain), as well as in Moffit Cancer Center (Tampa, Florida).
She is a member of the Board of the Spanish Society of Medical Oncology and member of the board of The Spanish Lung Cancer Group.
Her current research focuses on the treatment of thoracic tumors, with special interest in novel therapies against lung cancer, and clinical/translational research, her clinical and she has co-ordinated over 70 phase I-III trials in thoracic tumors
Rosário Campelo

Sean Parker

Dr Sean Parker is a Consultant Respiratory Physician at Northumbria Healthcare NHSFT. He trained in Oxford and Newcastle. In addition to being a general respiratory physician, he has run a specialist cough clinic since 2010 and has a particular interest in non-pharmacological cough control therapy, psychological aspects of cough and novel antitussives. Dr Parker is currently co chairing the BTS quality standards for cough group and NEurocough CRC and previously co-chaired the BTS clinical statement on cough in adults.